Sahajanand Medical Technologies IPO sees 34% Day 1 subscription
In short
Sahajanand Medical Technologies’ IPO moved into Day 2 on October 16, 2026. The issue had 34% subscription on Day 1 and a 12% grey market premium. The ₹475.48-crore offer for sale is priced at ₹327-344 per share.
The strong profit growth may support investor interest, but the final subscription outcome is still unknown. The reporting does not say how the IPO will close.
What the reporting says
Sahajanand Medical Technologies’ IPO entered Day 2 on October 16, 2026, after 34% subscription on Day 1 and a 12% grey market premium, with the ₹475.48-crore offer for sale priced at ₹327-344 per share. The company’s PAT rose 175% to ₹69 crore in FY26 alongside steady revenue growth. The reporting leaves open how demand develops over the rest of the issue period.
Why it matters
Sahajanand Medical Technologies’ IPO was reported on Day 2 with 34% subscription on Day 1 and a 12% grey market premium, for a ₹475.48-crore offer for sale priced at ₹327-344 per share. The company also reported PAT growth of 175% to ₹69 crore in FY26. The filing points to investor interest, but the final subscription and listing outcome are not stated in the available reporting.